MyCelx Technologies Corporation Progress Update on Trials (7735A)
01 Ottobre 2015 - 8:00AM
UK Regulatory
TIDMMYX TIDMMYXR
RNS Number : 7735A
MyCelx Technologies Corporation
01 October 2015
MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)
Progress Update on Trials
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the
clean water technology and engineering company providing patented
solutions to the Oil and Gas industry and other commercial
industrial markets worldwide, is pleased to provide an update on
trials relating to Enhanced Oil Recovery opportunities in
India.
MYCELX has been undertaking trials to increase its presence in
the Enhanced Oil Recovery ("EOR") market segment and is actively
pursuing opportunities in India, the Middle East and Canada. The
Company reports that it has received a new purchase order for a
paid trial to verify a further application of MYCELX products in
the treatment of produced water at EOR operations. MYCELX sees this
trial as the next important step in verifying its technological
advantage and in its pursuit of establishing its presence in India.
The paid trial was an expected next step for this ongoing project
and underpins revenue projections and the Company expects to be
able to report on the progress of the trial in Q1 2016.
For further information please contact:
MYCELX Technologies Corporation Tel: 1 888 306 6843
Connie Mixon, CEO
Kimberly Slayton, Interim
CFO
RFC Ambrian Limited Tel: 44 20 3440 6800
Corporate Finance
Samantha Harrison
Alexander Millar
Corporate Broking
Jonathan Williams
Kim Eckhof
Tel: 44 20 7260 1000
Numis Securities Limited
Corporate Broking
James Black
Ben Stoop
Tel: 44 20 7861 3232
Bell Pottinger
Nick Lambert
Henry Lerwill
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSDUFDSFISEEU
(END) Dow Jones Newswires
October 01, 2015 02:00 ET (06:00 GMT)
Grafico Azioni Mycelx Technologies (LSE:MYXR)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Mycelx Technologies (LSE:MYXR)
Storico
Da Mag 2023 a Mag 2024